Elite Pharmaceuticals, Inc. Impairment of Intangible Assets, Finite-lived
Elite Pharmaceuticals, Inc. (ELTP) reported Impairment of Intangible Assets, Finite-lived of $0 for the 9-month period ending 2025-12-31, per its 10-Q filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2026-02-17
- Elite Pharmaceuticals, Inc. impairment of intangible assets, finite-lived for the quarter ending 2025-12-31 was $0.00.
- Elite Pharmaceuticals, Inc. impairment of intangible assets, finite-lived for the quarter ending 2025-09-30 was $0.00.
- Elite Pharmaceuticals, Inc. impairment of intangible assets, finite-lived for the quarter ending 2025-06-30 was $0.00.
- Elite Pharmaceuticals, Inc. impairment of intangible assets, finite-lived for the quarter ending 2024-12-31 was $0.00.
- Elite Pharmaceuticals, Inc. impairment of intangible assets, finite-lived for fiscal 2014 was $0.00.
- Elite Pharmaceuticals, Inc. impairment of intangible assets, finite-lived for fiscal 2013 was $0.00.
- Elite Pharmaceuticals, Inc. impairment of intangible assets, finite-lived for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- Elite Pharmaceuticals, Inc. impairment of intangible assets, finite-lived for fiscal 2011 was $440.00K.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | |||
| 2024-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 10-Q · filed 2026-02-17 | $0.00 derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 3 quarters · filed 2025-11-14 | $0.00 derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 derived: sum of 2 quarters · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2025-08-14 | $0.00 derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2025-02-13 | $0.00 derived: sum of 2 quarters · filed 2025-02-13 | $0.00 derived: sum of 3 quarters · filed 2025-02-13 | $0.00 10-Q · filed 2025-02-13 |
| 2023-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $0.00 derived: sum of 2 quarters · filed 2025-02-13 | $0.00 10-Q · filed 2025-02-13 | |
| 2023-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-14 | |||
| 2014-03-31 | $0.00 10-K · filed 2014-06-30 | |||
| 2013-03-31 | $0.00 10-K · filed 2014-06-30 | |||
| 2012-03-31 | $0.00 10-K · filed 2013-06-21 | |||
| 2011-03-31 | $440.00K 10-K · filed 2012-06-29 |